AKT1 and cancer: Our previous study found that contactin 1, which is an adhesion molecule involved in carcinogenesis and cancer progression, accounts for drug resistance in SCLC by inducing Akt signaling pathway accompanied by epithelial–mesenchymal transition progression [19].